Science Before Market.
A knowledge-based biotechnology company, resting on proprietary technical know-how and an established record in international markets.
Wargah Sazan Kimia
Wargah Sazan Kimia Co. is a knowledge-based biotechnology and life sciences company. Our work is centred on developing proprietary biological products, most notably a heptavalent snake antivenom. We also provide specialist research and development, technology transfer and international regulatory services across the development and supply of pharmaceutical products.
- A certified knowledge-based company
- Developer of a proprietary heptavalent snake antivenom
- Three-time national top exporter
Certified Knowledge-Based Company
Recognized as an innovative knowledge-based company by the Vice-Presidency for Science and Technology, in the field of pharmaceuticals and advanced diagnostic and therapeutic products. Scan the QR code — or tap it — to open the registry.
Our Export Performance
With more than fifteen years of export experience and three national top exporter awards, our biological products have been supplied from Iran to markets across the Middle East, Asia, Europe and Latin America.
Wargah Sazan Kimia Co.
Export Network
Export Destinations
How the Company Took Shape and Grew
Born From a Research Project
The company did not begin as a commercial venture. It grew out of a scientific research project — research that became the foundation of the scientific and development path the company has followed since.
We Did Not Capture a Market — We Created One
The research took shape in answer to a need for which existing suppliers offered no suitable solution. Rather than competing for an existing market, we brought a new one into being.
First Biological Products Registered With the Iraqi Ministry of Health
We became the first company ever to register biological products with the Iraqi Ministry of Health — unprecedented in the ministry's history.
Scientific Representation & Export Growth
With the establishment of scientific representation abroad, the scope of exports widened and the international activity of the company developed.
Answering a Public-Health Gap
Understanding the needs of each market — and the weaknesses that put public health at risk — we began developing a proprietary product through scientific and field research.
A Knowledge-Based Proprietary Product
That continuous line of research led to the development of RasFab® — a proprietary heptavalent antivenom developed on the proprietary technical know-how of the company.
Three-Time National Top Exporter
Honored three times as a national top exporter for outstanding export performance in biological products — alongside dozens of other national and international awards.
A healthier future built on science, innovation and quality — where domestic knowledge drives the sustainable growth of the biotechnology industry.
To develop proprietary biological products and transfer technology in order to strengthen the scientific, manufacturing and pharmaceutical capacity of the region.
Research-first, quality-driven and built on international collaboration — from laboratory study through to manufacture and final supply.
Developing Advanced Biological Products
Our knowledge-based research and development infrastructure covers antigen design, formulation development and preparation of the manufacturing process, in line with international requirements and guidance including those of the WHO. That platform is the basis on which the rest of our projects and products are developed, and it is currently advancing products that few manufacturers worldwide are working on.
- Integrated development infrastructure, from antigen design to formulation
- Built to the highest international and WHO standards
- A sea snake antivenom now in development — answering a need very few products address worldwide
What Guides Us
“As the CEO of a knowledge-based biotechnology company, I believe that innovation, science, and quality are the driving forces behind a healthier future. Our mission is to develop, manufacture, and export high-quality biological and biopharmaceutical products that meet international standards while advancing technology transfer and fostering global partnerships. We remain committed to delivering innovative healthcare solutions that improve lives and contribute to the sustainable growth of the biotechnology industry.”
— Dr. Rahmani, Chief Executive Officer